JP6310923B2 - ジヒドロピリミジン誘導体の結晶形 - Google Patents
ジヒドロピリミジン誘導体の結晶形 Download PDFInfo
- Publication number
- JP6310923B2 JP6310923B2 JP2015533438A JP2015533438A JP6310923B2 JP 6310923 B2 JP6310923 B2 JP 6310923B2 JP 2015533438 A JP2015533438 A JP 2015533438A JP 2015533438 A JP2015533438 A JP 2015533438A JP 6310923 B2 JP6310923 B2 JP 6310923B2
- Authority
- JP
- Japan
- Prior art keywords
- xrpd
- powder
- peak
- ray diffraction
- crystal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210369019 | 2012-09-27 | ||
| CN201210369019.4 | 2012-09-27 | ||
| CN201310117076.8 | 2013-04-04 | ||
| CN201310117076 | 2013-04-04 | ||
| PCT/CN2013/084383 WO2014048355A1 (en) | 2012-09-27 | 2013-09-27 | Crystalline forms of dihydropyrimidine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015531354A JP2015531354A (ja) | 2015-11-02 |
| JP2015531354A5 JP2015531354A5 (https=) | 2018-02-08 |
| JP6310923B2 true JP6310923B2 (ja) | 2018-04-11 |
Family
ID=50355923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015533438A Active JP6310923B2 (ja) | 2012-09-27 | 2013-09-27 | ジヒドロピリミジン誘導体の結晶形 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9403814B2 (https=) |
| EP (1) | EP2900664B1 (https=) |
| JP (1) | JP6310923B2 (https=) |
| KR (1) | KR20150060610A (https=) |
| CN (3) | CN103724339B (https=) |
| AU (1) | AU2013324779B2 (https=) |
| BR (1) | BR112015002979B8 (https=) |
| CA (1) | CA2881260C (https=) |
| DK (1) | DK2900664T3 (https=) |
| ES (1) | ES2660642T3 (https=) |
| HU (1) | HUE037285T2 (https=) |
| MX (1) | MX362829B (https=) |
| MY (1) | MY171497A (https=) |
| PL (1) | PL2900664T3 (https=) |
| PT (1) | PT2900664T (https=) |
| RU (1) | RU2646599C2 (https=) |
| SG (1) | SG11201500145TA (https=) |
| TW (1) | TWI561520B (https=) |
| WO (1) | WO2014048355A1 (https=) |
| ZA (1) | ZA201500290B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015002954A (es) * | 2012-09-10 | 2015-06-05 | Hoffmann La Roche | Nuevas 6-aminoacido-heteroarilhidropirimidinas para el tratamiento y profilaxis de la infeccion del virus de la hepatitis b. |
| ES2794639T3 (es) * | 2015-11-04 | 2020-11-18 | Qilu Pharmaceutical Co Ltd | Forma cristalina, método de preparación y compuesto intermedio de compuesto con anillo dihidropirido |
| WO2017198201A1 (en) * | 2016-05-19 | 2017-11-23 | Sunshine Lake Pharma Co., Ltd. | Crystalline form, salt and complex of dihydropyrimidine derivative, and uses thereof in medicine |
| CN107722109B (zh) * | 2016-08-11 | 2020-12-18 | 广东东阳光药业有限公司 | 作为丙型肝炎病毒抑制剂的晶型 |
| US9856232B1 (en) * | 2017-06-20 | 2018-01-02 | King Saud University | Dihydropyrimidinone derivatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR043880A1 (es) * | 2003-04-22 | 2005-08-17 | Solvay Pharm Gmbh | Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas |
| WO2008154820A1 (fr) | 2007-06-18 | 2008-12-24 | Zhang, Zhongneng | Thiazolyl-dihydropyrimidines à substitution carbéthoxy |
| CN101328170B (zh) | 2007-06-18 | 2011-09-14 | 张中能 | 一种氟苯基-取代噻唑二氢嘧啶 |
| RU2443703C2 (ru) * | 2007-06-18 | 2012-02-27 | Саншайн Лейк Фарма Ко., Лтд | Бром-фенил замещенные тиазолилдигидропиримидины |
| WO2008154819A1 (fr) * | 2007-06-18 | 2008-12-24 | Zhang, Zhongneng | Thiazolyl-dihydropyrimidines à substitution carbéthoxy |
| CN101744823B (zh) * | 2008-12-17 | 2013-06-19 | 广东东阳光药业有限公司 | 一种二氢嘧啶类化合物的固体分散体及其药用制剂 |
| WO2010069147A1 (zh) * | 2008-12-17 | 2010-06-24 | 张中能 | 二氢嘧啶类化合物、其组合物及其应用 |
-
2013
- 2013-09-26 CN CN201310446506.0A patent/CN103724339B/zh active Active
- 2013-09-26 CN CN201310445326.0A patent/CN103694234A/zh active Pending
- 2013-09-26 CN CN201510364423.6A patent/CN104945394B/zh active Active
- 2013-09-26 TW TW102134813A patent/TWI561520B/zh active
- 2013-09-27 JP JP2015533438A patent/JP6310923B2/ja active Active
- 2013-09-27 CA CA2881260A patent/CA2881260C/en active Active
- 2013-09-27 RU RU2015114085A patent/RU2646599C2/ru active
- 2013-09-27 PL PL13841041T patent/PL2900664T3/pl unknown
- 2013-09-27 US US14/420,666 patent/US9403814B2/en active Active
- 2013-09-27 WO PCT/CN2013/084383 patent/WO2014048355A1/en not_active Ceased
- 2013-09-27 KR KR1020147037155A patent/KR20150060610A/ko not_active Ceased
- 2013-09-27 MY MYPI2015700253A patent/MY171497A/en unknown
- 2013-09-27 EP EP13841041.0A patent/EP2900664B1/en active Active
- 2013-09-27 ES ES13841041.0T patent/ES2660642T3/es active Active
- 2013-09-27 PT PT138410410T patent/PT2900664T/pt unknown
- 2013-09-27 BR BR112015002979A patent/BR112015002979B8/pt active IP Right Grant
- 2013-09-27 DK DK13841041.0T patent/DK2900664T3/en active
- 2013-09-27 AU AU2013324779A patent/AU2013324779B2/en active Active
- 2013-09-27 SG SG11201500145TA patent/SG11201500145TA/en unknown
- 2013-09-27 HU HUE13841041A patent/HUE037285T2/hu unknown
- 2013-09-27 MX MX2015004115A patent/MX362829B/es active IP Right Grant
-
2015
- 2015-01-15 ZA ZA2015/00290A patent/ZA201500290B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108395452B (zh) | 作为钠通道调节剂的吡啶酮酰胺的前药 | |
| KR101424013B1 (ko) | 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산의 결정형과 그의 제조방법 | |
| EP3013815B1 (en) | Carbazole carboxamide compounds useful as kinase inhibitors | |
| EP2595969B1 (en) | Substituted 3-phenyl-1,2,4-oxadiazole compounds | |
| JP2018525379A (ja) | Ｔｎｆアルファの修飾因子として有用なヘテロ環化合物 | |
| HU217428B (hu) | 3-(5-Tetrazolil-benzil)-amino-piperidin-származékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyászati készítmények | |
| JP6310923B2 (ja) | ジヒドロピリミジン誘導体の結晶形 | |
| AU2018208846A1 (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as magl inhibitors | |
| JPH04230681A (ja) | １，４‐ベンゾチアゼピン誘導体 | |
| US20170355673A1 (en) | Tricyclic atropisomer compounds | |
| EP2619190B1 (en) | Substituted oxadiazole compounds and their use as s1p1 agonists | |
| JP2019511466A (ja) | オレキシン受容体調節因子としてのハロ置換ピペリジン | |
| JP2024517963A (ja) | ブルトン型チロシンキナーゼ阻害剤の共結晶形態 | |
| TW202136237A (zh) | RORγt抑制劑及其製備方法和用途 | |
| HK1207081B (en) | Crystalline forms of dihydropyrimidine derivatives | |
| US20050004200A1 (en) | Pyrazole compounds as integrin receptor antagonists derivatives | |
| JP2008526828A (ja) | 逆転写酵素モジュレーターとしてのイミダゾール誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160915 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160915 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170607 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170613 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20170906 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170907 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171121 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20171225 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180205 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180220 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180319 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6310923 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |